4Liu JJ,Peng L,Bradley CJ,et al.Increased apoptosis in the heart of genetic hypertension,associated with increased fibroblasts.Cardiovasc Res,2000,45:729.
5YU G,LIANG X,XIE X,et al.Apoptosis,myocardial fibrosis and angiotensinⅡin the left ventricle of hypertensive rats treated with fosinopril or losartan.Chin Med J(Engl),2002,115(9):1287.
6Ravassa S,Fortuno MA,Conzalez A,et al.Mechanisms of increased susceptibility to angiotensin Ⅱ induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats.Hypertension,2000,36:1065.
7Eisner DA,Trafford AW,Diaz ME,et al.The control of Ca release from the sarcoplasmic reticulum:regulation versus autoregulation.Cardiovasc Res,1998,38:589.
8Jugutt B.Menon V.AT1 receptor blockade limits myocardial injury and up regulates AT2 receptors during reperfused myocardial infarction1 Mol Cell Biochem,2004,260:111.
2Linz W,Wiemer G,Scholkens BA.Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.Am J Cardial,1997,80:118A-23A.
3Campbell DJ,Krum H,Esler MD.Losartan increases bradykinin levels in hypertensive humans.Circulation,2005,111:315-320.
4Tsutsumi Y,Matsubara H,Masaki H,et al.AngiotensinⅡ type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.J Clin Invest,1999,104:925-935.
5Liu YH,Xu J,Yang XF,et al.Effect of ACE inhibitors and angiotensin Ⅱtype 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.Hyperten,2002,39:375-381.
6Xu J,Carretero OA,Liu YH,et al.Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.Hypertension,2002,40:244-250.
7Schulz R,Heusch G.AT1-receptor blockade in experimental myocardial ischemia/reperfusion.J Clin Nephrol,2003,60:67-74.
9Barsotti A ,Di Napoli P,Taccardi AA,et al.MK-954(losartan potassium) exert endothelial protective effects against reperfusion injury:evidenced of an e-NOS mRNA overexpression after global ischemia.J Atherosclerosis,2001,155:53-59.
10Shimizu M,Wang QD,Sjoquist PO,et al.The angiotensin II AT1-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts.J Cardiovasc Pharmacol,1999,34:78-81.
